Royalty Pharma plc
RPRX
Classement en actions
#895
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Prix de l'action
$60.39
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$26.89B
Changement (1 jour)
-0.93%
Changement (1 an)
64.87%
Pays
US
Échange Royalty Pharma plc (RPRX)
Catégorie
Healthcare
Historique des dividendes pour Royalty Pharma plc (RPRX)
Royalty Pharma plc (symbole boursier : RPRX) a versé un total de 23 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : $4.50
Rendement du dividende (TTM) : 0.0157
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : $4.50
Rendement du dividende (TTM) : 0.0157
Versements de dividendes pour Royalty Pharma plc (RPRX) de 2020 à 2026
Versements annuels de dividendes
| Année | Dividende (ajusté pour divisions d’actions) | Changez |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Liste de tous les paiements de dividendes
| Année | Dividende | Changez |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Dividendes versés par des entreprises similaires ou concurrentes
| Entreprise | Nombre de paiements de dividendes | Pays |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 69.00% |
HK
|
|
| 0.00% |
US
|
